Papageorgiou, S. G., Kotsianidis, I., Kontos, C. K., Symeonidis, A., Galanopoulos, A., Hatzimichael, E., Poulakidas, E., Diamantopoulos, P., Vassilakopoulos, T. P., Zikos, P., Papadaki, H., Bouronikou, E., Panayiotidis, P., Viniou, N., & Pappa, V. (2018). body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group. Leukemia research, 71, 55–59. http://access.bl.uk/ark:/81055/vdc_100066554178.0x00004c